News and Trends 15 Nov 2014
Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?
The French company Servier wants to invest one billion euros by a partnering with the American company Intarcia regarding their subcutaneous implant for diabetes. This is a breakthrough micropump, the first device without injection able to deliver the molecule Exenatide during one year. It is a huge step forward in treating type 2 diabetes. Indeed, most people forget […]
